Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016;3(3):e1397.
doi: 10.14800/ics.1397. Epub 2016 Aug 22.

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: flip side of the story

Yohannes T Ghebre  1
Affiliations
Comment

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: flip side of the story

Yohannes T Ghebre. Inflamm Cell Signal. 2016.
No abstract available

Keywords: Antacid therapy; gastroesophageal reflux; idiopathic pulmonary fibrosis; pirfenidone; proton pump inhibitors.

PubMed Disclaimer

Conflict of interest statement

Conflicting interests YTG is an inventor on patents, owned by Stanford University, that protect the use of agents, including the PPIs, for therapeutic use of new indications including IPF. YTG is a cofounder of Altitude Pharma, Inc.; a biotechnology company developing PPI-based therapy for IPF.

Figures

Figure 1
Figure 1. Odds ratio of adjusted data showing the effect of antacid therapy at 1-year when
A) compared with placebo or B) combined with pirfenidone. Odds ratio (median value) and 95% CI is shown in both dataset. Dataset A is drawn from Table 5 of Kreuter et al and Dataset B is re-drawn from data presented by Kreuter et al ATS 2016.
See this image and copyright information in PMC

Comment on

References

    1. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136–142. - PubMed
    1. Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131:438–446. - PubMed
    1. Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest. 2006;129:794–800. - PubMed
    1. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:1390–1394. - PMC - PubMed
    1. Lee JCH, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G, for the IPFnet Investigators Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. The Lancet Respiratory Medicine. 2013;1:369–376. - PMC - PubMed

LinkOut - more resources